Glaukos Corp
(NYSE : GKOS)

( )
GKOS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.27%90.630.6%$534.38m
ABTAbbott Laboratories
0.33%78.230.8%$449.66m
ALGNAlign Technology, Inc.
0.52%271.026.3%$422.26m
TMOThermo Fisher Scientific Inc.
1.90%268.811.0%$416.46m
ISRGIntuitive Surgical, Inc.
0.26%562.722.4%$320.80m
EWEdwards Lifesciences Corporation
0.20%189.371.2%$287.44m
BSXBoston Scientific Corporation
0.89%37.631.1%$268.95m
BDXBecton, Dickinson and Company
0.49%241.291.1%$244.79m
SYKStryker Corporation
0.39%195.201.3%$226.20m
BAXBaxter International Inc.
0.50%77.631.7%$213.32m
TNDMTandem Diabetes Care, Inc.
0.55%69.144.1%$202.65m
DXCMDexCom, Inc.
-3.84%124.088.5%$193.28m
ZBHZimmer Biomet Holdings, Inc.
-0.09%126.571.7%$151.17m
WATWaters Corporation
0.35%246.233.5%$139.42m
ABMDABIOMED, Inc.
-3.09%313.223.3%$132.19m

Company Profile

Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.